結直腸癌轉移灶的綜合治療_《中國普外基礎與臨床雜志》

作者：

薛霧松 , 門斯燁 , 張少輝 , 余文 , 劉會良 , 劉寶清 , 楊成城 , 吳偉

北京中醫藥大學東方醫院普通外科（北京　100078）;

關鍵詞：

結直腸癌肝轉移肺轉移腹膜轉移綜合治療

視頻：

導出 下載 收藏 掃碼 引用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

引用本文： 薛霧松,門斯燁,張少輝,余文,劉會良,劉寶清,楊成城,吳偉. 結直腸癌轉移灶的綜合治療. 中國普外基礎與臨床雜志, 2012, 19(8): 894-898. doi: 復制

1.	?Weiser MR， Landmann RG， Kattan MW， et al. Individualized prediction of colon cancer recurrence using a nomogram[J]. J Clin Oncol， 2008， 26(3)：380-385.
2.	Kattan MW， Gönen M， Jarnagin WR， et al. A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer[J]. Ann Surg， 2008， 247(2)：282-287.
3.	Kemeny N， Fata F. Arterial，portal， or systemic chemotherapy for patients with hepatic metastasis of colorectal carcinoma[J]. J Hepatobiliary Pancreat Surg， 1999， 6(1)：39-49.
4.	McMahon G. VEGF receptor signaling in tumor angiogenesis[J]. Oncologist， 2000， 5 Suppl 1：3-10.
5.	Borner M， Laffer U， Ludwig C，et al. Effectiveness and low toxicity of hepatic artery infusion with fluorouracil and mitomycin for metastatic colorectal cancer confined to the liver. The Swiss Group for Clinical and Epidemiological Cancer Research (SAKK)[J]. Ann Oncol， 1990， 1(3)：227-228.
6.	Kato T， Yasui K， Hirai T， et al. Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy：analysis of prognostic factors for 763 cases recorded at 18 institutions[J]. Dis Colon Rectum， 2003， 46(10 Suppl)：S22-S31.
7.	Foster JH， Berman MM. Solid Liver Tumors. Major Problem in Clinical Surgery[M]. Philadelphia， PA：W. B. Saunders Company， 1977：1-342.
8.	Lise M， Da Pian PP， Nitti D， et al. Colorectal metastases to the liver：present status of management[J]. Dis Colon Rectum， 1990， 33(8)：688-694.
9.	Fong Y， Cohen AM， Fortner JG， et al. Liver resection for colorectal metastases[J]. J Clin Oncol， 1997， 15(3)：938-946.
10.	Fong Y， Fortner J， Sun RL， et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer：analysis of 1 001 consecutive cases[J]. Ann Surg， 1999， 230(3)：309-318.
11.	Bismuth H， Adam R， Lévi F， et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy[J]. Ann Surg， 1996， 224(4)：509-520.
12.	Hemming AW， Reed AI， Howard RJ， et al. Preoperative portal vein embolization for extended hepatectomy[J]. Ann Surg， 2003， 237(5)：686-691.
13.	Niu R， Yan T， Zhu J， et al．Recurrence and survival outcomes after hepatic resection with or without cryotherapy for liver metastases from colorectal carcinoma[J]. Ann Surg Oncol， 2007， 14(7)：2078-2087.
14.	Gleisner AL， Choti MA， Assumpcao L， et al. Colorectal liver metastases：recurrence and survival following hepatic resection， radiofrequency ablation， and combined resection-radiofrequency ablation[J]. Arch Surg， 2008， 143(12)：1204-1212.
15.	Hemming AW， Reed AI， Langham MR Jr， et al. Combined resection of the liver and inferior vena cava for hepatic malignancy[J]. Ann Surg， 2004， 239(5)：712-721.
16.	Adam R， Miller R， Pitombo M， et al. Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases[J]. Surg Oncol Clin N Am， 2007， 16(3)：525-536.
17.	Barlow AD， Nakas A， Pattenden C， et al. Surgical treatment of combined hepatic and pulmonary colorectal cancer metastases[J]. Eur J Surg Oncol， 2009， 35(3)：307-312.
18.	Chua TC， Yan TD， Zhao J， et al. Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection[J]. Eur J Surg Oncol， 2009， 35(12)：1299-1305.
19.	Simmonds PC， Primrose JN， Colquitt JL， et al. Surgical resection of hepatic metastases from colorectal cancer：a systematic review of published studies[J]. Br J Cancer， 2006， 94(7)：982-999.
20.	Charnsangavej C， Clary B， Fong Y， et al. Selection of patients for resection of hepatic colorectal metastases：expert consensus statement[J]. Ann Surg Oncol， 2006， 13(10)：1261-1268.
21.	Nordlinger B， Van Cutsem E， Gruenberger T， et al. Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases：recommendations from an expert panel[J]. Ann Oncol， 2009， 20(6)：985-992.
22.	Nordlinger B， Sorbye H， Glimelius B， et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983)：a randomised controlled trial[J]. Lancet， 2008， 371(9617)：1007-1016.
23.	Nakano H， Oussoultzoglou E， Rosso E， et al. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy[J]. Ann Surg， 2008， 247(1)：118-124.
24.	Adam R， Wicherts DA， de Haas RJ， et al. Complete pathologic response after preoperative chemotherapy for colorectal liver metastases：myth or reality?[J]. J Clin Oncol， 2008， 26(10)：1635-1641.
25.	Pawlik TM， Schulick RD， Choti MA. Expanding criteria for resectability of colorectal liver metastases[J]. Oncologist， 2008， 13(1)：51-64.
26.	McCormack P， Attiyeh F. Resected pulmonary metastases from colorectal cancer[J]. Dis Colon Rectum， 1979， 22(8)：553-556.
27.	McCormack PM， Burt ME， Bains MS， et al. Lung resection for colorectal metastases. 10-year results[J]. Arch Surg， 1992， 127(12)：1403-1406.
28.	Saito Y， Omiya H， Kohno K， et al. Pulmonary metastasectomy for 165 patients with colorectal carcinoma：A prognostic assessment[J]. J Thorac Cardiovasc Surg， 2002， 124(5)：1007-1013.
29.	Welter S， Jacobs J， Krbek T， et al. Prognostic impact of lymph node involvement in pulmonary metastases from colorectal cancer[J]. Eur J Cardiothorac Surg， 2007， 31(2)：167-172.
30.	Iizasa T， Suzuki M， Yoshida S， et al. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer[J]. Ann Thorac Surg， 2006， 82(1)：254-260.
31.	Rena O， Casadio C， Viano F， et al. Pulmonary resection for metastases from colorectal cancer：factors influencing prognosis. Twenty-year experience[J]. Eur J Cardiothorac Surg， 2002， 21(5)：906-912.
32.	International Registry of Lung Metastases. Long-term results of lung metastasectomy：prognostic analyses based on 5 206 cases[J]. J Thorac Cardiovasc Surg， 1997， 113(1)：37-49.
33.	Pfannschmidt J， Dienemann H， Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer：a systematic review of published series[J]. Ann Thorac Surg， 2007， 84(1)：324-338.
34.	McKenna RJ Jr， Houck W， Fuller CB. Video-assisted thoracic surgery lobectomy：experience with 1 100 cases[J]. Ann Thorac Surg， 2006， 81(2)：421-425.
35.	Koppe MJ， Boerman OC， Oyen WJ， et al. Peritoneal carcinomatosis of colorectal origin：incidence and current treatment strategies[J]. Ann Surg， 2006， 243(2)：212-222.
36.	Sadeghi B， Arvieux C， Glehen O， et al. Peritoneal carcinomatosis from non-gynecologic malignancies：results of the EVOCAPE1 multicentric prospective study[J]. Cancer， 2000， 88(2)：358-363.
37.	Cunningham D， Humblet Y， Siena S， et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer[J]. N Engl J Med， 2004， 351(4)：337-345.
38.	Sugarbaker PH. Peritonectomy procedures[J]. Ann Surg， 1995， 221(1)：29-42.
39.	Verwaal VJ， van Ruth S， de Bree E， et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer[J]. J Clin Oncol， 2003， 21(20)：3737-3743.
40.	Glehen O， Kwiatkowski F， Sugarbaker PH， et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer：a multi-institutional study[J]. J Clin Oncol， 2004， 22(16)：3284-3292.
41.	Yan TD， Black D， Savady R， et al. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma[J]. J Clin Oncol， 2006， 24(24)：4011-4019.
42.	Elias D， Lefevre JH， Chevalier J， et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin[J]. J ClinOncol， 2009， 27(5)：681-685.
43.	Chua TC， Yan TD， Saxena A， et al. Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? a systematic review of morbidity and mortality[J]. Ann Surg， 2009， 249(6)：900-907.

1. 　?Weiser MR， Landmann RG， Kattan MW， et al. Individualized prediction of colon cancer recurrence using a nomogram[J]. J Clin Oncol， 2008， 26(3)：380-385.
2. Kattan MW， Gönen M， Jarnagin WR， et al. A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer[J]. Ann Surg， 2008， 247(2)：282-287.
3. Kemeny N， Fata F. Arterial，portal， or systemic chemotherapy for patients with hepatic metastasis of colorectal carcinoma[J]. J Hepatobiliary Pancreat Surg， 1999， 6(1)：39-49.
4. McMahon G. VEGF receptor signaling in tumor angiogenesis[J]. Oncologist， 2000， 5 Suppl 1：3-10.
5. Borner M， Laffer U， Ludwig C，et al. Effectiveness and low toxicity of hepatic artery infusion with fluorouracil and mitomycin for metastatic colorectal cancer confined to the liver. The Swiss Group for Clinical and Epidemiological Cancer Research (SAKK)[J]. Ann Oncol， 1990， 1(3)：227-228.
6. Kato T， Yasui K， Hirai T， et al. Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy：analysis of prognostic factors for 763 cases recorded at 18 institutions[J]. Dis Colon Rectum， 2003， 46(10 Suppl)：S22-S31.
7. Foster JH， Berman MM. Solid Liver Tumors. Major Problem in Clinical Surgery[M]. Philadelphia， PA：W. B. Saunders Company， 1977：1-342.
8. Lise M， Da Pian PP， Nitti D， et al. Colorectal metastases to the liver：present status of management[J]. Dis Colon Rectum， 1990， 33(8)：688-694.
9. Fong Y， Cohen AM， Fortner JG， et al. Liver resection for colorectal metastases[J]. J Clin Oncol， 1997， 15(3)：938-946.
10. Fong Y， Fortner J， Sun RL， et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer：analysis of 1 001 consecutive cases[J]. Ann Surg， 1999， 230(3)：309-318.
11. Bismuth H， Adam R， Lévi F， et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy[J]. Ann Surg， 1996， 224(4)：509-520.
12. Hemming AW， Reed AI， Howard RJ， et al. Preoperative portal vein embolization for extended hepatectomy[J]. Ann Surg， 2003， 237(5)：686-691.
13. Niu R， Yan T， Zhu J， et al．Recurrence and survival outcomes after hepatic resection with or without cryotherapy for liver metastases from colorectal carcinoma[J]. Ann Surg Oncol， 2007， 14(7)：2078-2087.
14. Gleisner AL， Choti MA， Assumpcao L， et al. Colorectal liver metastases：recurrence and survival following hepatic resection， radiofrequency ablation， and combined resection-radiofrequency ablation[J]. Arch Surg， 2008， 143(12)：1204-1212.
15. Hemming AW， Reed AI， Langham MR Jr， et al. Combined resection of the liver and inferior vena cava for hepatic malignancy[J]. Ann Surg， 2004， 239(5)：712-721.
16. Adam R， Miller R， Pitombo M， et al. Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases[J]. Surg Oncol Clin N Am， 2007， 16(3)：525-536.
17. Barlow AD， Nakas A， Pattenden C， et al. Surgical treatment of combined hepatic and pulmonary colorectal cancer metastases[J]. Eur J Surg Oncol， 2009， 35(3)：307-312.
18. Chua TC， Yan TD， Zhao J， et al. Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection[J]. Eur J Surg Oncol， 2009， 35(12)：1299-1305.
19. Simmonds PC， Primrose JN， Colquitt JL， et al. Surgical resection of hepatic metastases from colorectal cancer：a systematic review of published studies[J]. Br J Cancer， 2006， 94(7)：982-999.
20. Charnsangavej C， Clary B， Fong Y， et al. Selection of patients for resection of hepatic colorectal metastases：expert consensus statement[J]. Ann Surg Oncol， 2006， 13(10)：1261-1268.
21. Nordlinger B， Van Cutsem E， Gruenberger T， et al. Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases：recommendations from an expert panel[J]. Ann Oncol， 2009， 20(6)：985-992.
22. Nordlinger B， Sorbye H， Glimelius B， et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983)：a randomised controlled trial[J]. Lancet， 2008， 371(9617)：1007-1016.
23. Nakano H， Oussoultzoglou E， Rosso E， et al. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy[J]. Ann Surg， 2008， 247(1)：118-124.
24. Adam R， Wicherts DA， de Haas RJ， et al. Complete pathologic response after preoperative chemotherapy for colorectal liver metastases：myth or reality?[J]. J Clin Oncol， 2008， 26(10)：1635-1641.
25. Pawlik TM， Schulick RD， Choti MA. Expanding criteria for resectability of colorectal liver metastases[J]. Oncologist， 2008， 13(1)：51-64.
26. McCormack P， Attiyeh F. Resected pulmonary metastases from colorectal cancer[J]. Dis Colon Rectum， 1979， 22(8)：553-556.
27. McCormack PM， Burt ME， Bains MS， et al. Lung resection for colorectal metastases. 10-year results[J]. Arch Surg， 1992， 127(12)：1403-1406.
28. Saito Y， Omiya H， Kohno K， et al. Pulmonary metastasectomy for 165 patients with colorectal carcinoma：A prognostic assessment[J]. J Thorac Cardiovasc Surg， 2002， 124(5)：1007-1013.
29. Welter S， Jacobs J， Krbek T， et al. Prognostic impact of lymph node involvement in pulmonary metastases from colorectal cancer[J]. Eur J Cardiothorac Surg， 2007， 31(2)：167-172.
30. Iizasa T， Suzuki M， Yoshida S， et al. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer[J]. Ann Thorac Surg， 2006， 82(1)：254-260.
31. Rena O， Casadio C， Viano F， et al. Pulmonary resection for metastases from colorectal cancer：factors influencing prognosis. Twenty-year experience[J]. Eur J Cardiothorac Surg， 2002， 21(5)：906-912.
32. International Registry of Lung Metastases. Long-term results of lung metastasectomy：prognostic analyses based on 5 206 cases[J]. J Thorac Cardiovasc Surg， 1997， 113(1)：37-49.
33. Pfannschmidt J， Dienemann H， Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer：a systematic review of published series[J]. Ann Thorac Surg， 2007， 84(1)：324-338.
34. McKenna RJ Jr， Houck W， Fuller CB. Video-assisted thoracic surgery lobectomy：experience with 1 100 cases[J]. Ann Thorac Surg， 2006， 81(2)：421-425.
35. Koppe MJ， Boerman OC， Oyen WJ， et al. Peritoneal carcinomatosis of colorectal origin：incidence and current treatment strategies[J]. Ann Surg， 2006， 243(2)：212-222.
36. Sadeghi B， Arvieux C， Glehen O， et al. Peritoneal carcinomatosis from non-gynecologic malignancies：results of the EVOCAPE1 multicentric prospective study[J]. Cancer， 2000， 88(2)：358-363.
37. Cunningham D， Humblet Y， Siena S， et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer[J]. N Engl J Med， 2004， 351(4)：337-345.
38. Sugarbaker PH. Peritonectomy procedures[J]. Ann Surg， 1995， 221(1)：29-42.
39. Verwaal VJ， van Ruth S， de Bree E， et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer[J]. J Clin Oncol， 2003， 21(20)：3737-3743.
40. Glehen O， Kwiatkowski F， Sugarbaker PH， et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer：a multi-institutional study[J]. J Clin Oncol， 2004， 22(16)：3284-3292.
41. Yan TD， Black D， Savady R， et al. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma[J]. J Clin Oncol， 2006， 24(24)：4011-4019.
42. Elias D， Lefevre JH， Chevalier J， et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin[J]. J ClinOncol， 2009， 27(5)：681-685.
43. Chua TC， Yan TD， Saxena A， et al. Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? a systematic review of morbidity and mortality[J]. Ann Surg， 2009， 249(6)：900-907.

《中國普外基礎與臨床雜志》

結直腸癌轉移灶的綜合治療

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

《中國普外基礎與臨床雜志》

結直腸癌轉移灶的綜合治療

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

摘要全文圖表視頻參考文獻施引文獻補充材料